You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory to standard treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tachycardia, Ventricular Trial in Dallas (Stereotactic ablative radiotherapy)

Withdrawn
  • Tachycardia, Ventricular
  • Stereotactic ablative radiotherapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center - Dallas
Aug 15, 2022

AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

Not yet recruiting
  • AML, Adult
  • Pharmacoscopy
  • Clinical standard-of-care (physician's choice)
  • (no location specified)
Nov 20, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Chronic Cervical Radiculopathy Trial (radiofrequency ablation)

Not yet recruiting
  • Chronic Cervical Radiculopathy
  • radiofrequency ablation
  • (no location specified)
Feb 18, 2023

Immune-related Adverse Events Refractory to Standard Therapy and

Recruiting
  • Immune-related Adverse Event
  • Extracorporeal photopheresis
  • Other immunosuppressive or immunomodulatory drugs
  • Munich, Germany
    LMU Klinikum Hauttumorzentrum
Jan 17, 2023

Hawthorn Red Combined Refractory Cancer Pain Trial (Hawthorn red pigment)

Not yet recruiting
  • Hawthorn Red Combined Refractory Cancer Pain
  • Hawthorn red pigment
  • (no location specified)
Sep 26, 2022

Cardiac Arrhythmia, Cardiac, Ventricular Tachyarrhythmias Trial in Houston (stereotactic ablative radiotherapy (SABR), Standard

Not yet recruiting
  • Cardiac Arrhythmia
  • +2 more
  • stereotactic ablative radiotherapy (SABR)
  • Standard of Treatment
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Refractory Status Epilepticus Trial in Worldwide (Ganaxolone, Placebo, Standard of care)

Not yet recruiting
  • Refractory Status Epilepticus
  • Bruxelles, Belgium
  • +11 more
Apr 3, 2023

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Epilepsy Trial in Toulouse (DIXI Medical Microdeep® Micro- Macro Depth electrodes, Standard electrodes)

Not yet recruiting
  • Epilepsy
  • DIXI Medical Microdeep® Micro- Macro Depth electrodes
  • Standard electrodes
  • Toulouse, France
    University Hospital of Toulouse
Oct 30, 2023

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • TACE and HAIC Combined With Regorafenib
  • Guangzhou, Guangdong, China
    the first affiliated hospital, Sun-Yat sen university
Oct 2, 2023

DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

Recruiting
  • Solid Tumor
  • Individuation
  • Recommended treatment plan
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Aug 23, 2023

Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Axicabtagene Ciloleucel
  • +8 more
  • Denver, Colorado
  • +6 more
Dec 2, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Semi-automated Segmentation Methods of SSTR PET for Dosimetry

Not yet recruiting
  • Refractory Meningioma
  • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
  • (no location specified)
Sep 8, 2022

Pediatric Oncology Trial in Worldwide (Regorafenib (BAY73-4506), Vincristine (Cellcristin®), Irinotecan (Irinotecan Cell

Active, not recruiting
  • Pediatric Oncology
  • Regorafenib (BAY73-4506)
  • +2 more
  • Lyon, France
  • +11 more
Jan 16, 2023

Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)

Suspended
  • Unspecified Adult Solid Tumor, Protocol Specific
  • RNR inhibitor COH29
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Ascites Trial in Houston (Albumin)

Recruiting
  • Ascites
  • Houston, Texas
    Baylor St' Lukes Medical center
May 10, 2023

Telemedicine Trial in Durham, Richmond (PRACTICE-DM, Standard VA Home Telehealth)

Completed
Has Results
  • Telemedicine
  • PRACTICE-DM
  • Standard VA Home Telehealth
  • Durham, North Carolina
  • +1 more
Apr 29, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

Thyroid Cancer, Thyroid, Refractory Thyroid Cancer Trial in New York (Surveillance Visit)

Recruiting
  • Thyroid Cancer
  • +2 more
  • Surveillance Visit
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 8, 2023